Insulet Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Insulet Corporation (PODD) PT Raised to $58 at Jefferies
August 4, 2017 8:38 AM EDTJefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a Buy rating following the company's 2Q conference call.
The company provided more detail on the plans it announced on July 20 to abandon its distributor Ypsomed and go... More
Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats
August 3, 2017 5:45 PM EDTInsulet (NASDAQ: PODD) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $109.8 million versus the consensus estimate of $106.17 million.
GUIDANCE:
Insulet sees Q3 2017 revenue of $112-116 million, versus the consensus of $110.4... More
